Is there a role for aspirin 81 mg daily in patients with nonischemic dilated cardiomyopathy with reduced EF?

When there are other indications for antiplatelet therapy such as history of stroke, PVD, etc., Aspirin has a role in pharmacological therapy of patients with non-ischemic dilated cardiomyopathy and a reduced left ventricular ejection fraction. However, in the absence of coexisting indications, ther...

I agree—there is no benefit to anticoagulation or ASA in this population.

And to note, based on the CORONA study, there is no use for rosuvastatin in this patient population with no CAD and nonischemic CMP. Those patients appeared to do worse, probably because statins can cause some degree of muscle ...

I agree that current data do not support either anticoagulation or aspirin for patients with heart failure and reduced ejection fraction in the absence of another indication for their use. However, in the WARCEF trial, although there was no difference between aspirin and warfarin overall, there was ...